F2G Ltd Appoints Ian Nicholson as CEO
3/18/2013 9:05:45 AM
More...
|
F2G Ltd Appoints John H. Rex to Board of Directors
2/19/2013 12:36:54 PM
More...
|
F2G Ltd Raises $30 Million to Fund Pre-Clinical and Clinical Development of Novel Anti-Fungal Compounds
9/5/2012 6:40:47 AM
More...
|
F2G Ltd Announces the Appointment of Michael R. Hodges, M.D. to the Board of Directors
9/13/2010 2:39:41 PM
More...
|
F2G Ltd Announces the Appointment of Dr Richard J. White as Chairman of the Board of Directors
2/24/2010 2:19:37 PM
More...
|
F2G Ltd Initiates Phase I Clinical Trial for FG3622
7/7/2009 10:55:22 AM
More...
|
F2G Ltd Announces Key Appointment and a Consolidation of the Management Team
2/12/2009 11:59:23 AM
More...
|
F2G Ltd Announces Presentations at 48th Interscience Conference on Antimicrobial Agents and Chemotherapy(ICAAC)
10/24/2008 9:21:12 AM
More...
|
F2G Ltd Completes £6.3 Million Financing Round to Fund Preclinical and Clinical Development
8/19/2008 9:13:40 AM
More...
|
F2G Ltd Announces Appointment Of New Chief Scientific Officer
1/12/2007 10:20:36 AM
More...
|
|